|
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging growth company |
Common Stock, $0.01 par value
|
|
(Title of Class)
|
(Outstanding as of February 7, 2022)
|
Page
|
||
PART I
|
||
Item 1.
|
Financial Statements
|
|
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
8
|
||
Item 2.
|
25
|
|
Item 3.
|
34
|
|
Item 4.
|
34
|
|
PART II
|
||
Item 1.
|
34
|
|
Item 1A.
|
34
|
|
Item 2.
|
34
|
|
Item 3.
|
35
|
|
Item 4.
|
35
|
|
Item 5.
|
35
|
|
Item 6.
|
35
|
|
36
|
December 31, 2021
|
September 30, 2021
|
|||||||
(unaudited)
|
||||||||
ASSETS
|
||||||||
Cash and non-interest-bearing deposits due from banks
|
$
|
|
$
|
|
||||
Interest-bearing deposits due from banks
|
|
|
||||||
Federal funds sold
|
|
|
||||||
Total cash and cash equivalents
|
|
|
||||||
Securities:
|
||||||||
Held to maturity (fair value of $
|
|
|
||||||
Available for sale, at fair value
|
|
|
||||||
Total securities
|
|
|
||||||
Loans held for investment
|
|
|
||||||
Allowance for loan losses
|
(
|
)
|
(
|
)
|
||||
Loans held for investment, net
|
|
|
||||||
Premises and equipment, net
|
|
|
||||||
Accrued interest receivable
|
|
|
||||||
Prepaid pension
|
|
|
||||||
Stock in Federal Home Loan Bank, at cost
|
|
|
||||||
Goodwill
|
|
|
||||||
Other intangible assets
|
|
|
||||||
Loan servicing rights
|
||||||||
Deferred income taxes |
||||||||
Other assets
|
|
|
||||||
TOTAL ASSETS
|
$
|
|
$
|
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Deposits:
|
||||||||
Non-interest-bearing demand
|
$
|
|
$
|
|
||||
Savings, NOW and money market
|
|
|
||||||
Time
|
|
|
||||||
Total deposits
|
|
|
||||||
Borrowings
|
|
|
||||||
Subordinated debentures
|
|
|
||||||
Accrued interest payable
|
|
|
||||||
Other liabilities
|
|
|
||||||
TOTAL LIABILITIES
|
|
|
||||||
COMMITMENTS AND CONTINGENT LIABILITIES | - |
- |
||||||
STOCKHOLDERS' EQUITY
|
||||||||
Preferred stock (par value $
|
|
|
||||||
Common stock (par value $
|
|
|
||||||
Surplus
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive income, net of tax
|
|
|
||||||
TOTAL STOCKHOLDERS' EQUITY
|
|
|
||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
|
$
|
|
Three Months Ended
December 31,
|
||||||||
2021
|
2020
|
|||||||
INTEREST INCOME
|
||||||||
Loans
|
$
|
|
$
|
|
||||
Taxable securities
|
|
|
||||||
Federal funds sold
|
|
|
||||||
Other interest income
|
|
|
||||||
Total interest income
|
|
|
||||||
INTEREST EXPENSE
|
||||||||
Savings, NOW and money market deposits
|
|
|
||||||
Time deposits
|
|
|
||||||
Borrowings
|
|
|
||||||
Total interest expense
|
|
|
||||||
Net interest income
|
|
|
||||||
Provision for loan losses
|
|
|
||||||
Net interest income after provision for loan losses
|
|
|
||||||
NON-INTEREST INCOME
|
||||||||
Loan servicing and fee income
|
|
|
||||||
Service charges on deposit accounts
|
|
|
||||||
Gain on sale of loans held-for-sale
|
|
|
||||||
Other income
|
|
|
||||||
Total non-interest income
|
|
|
||||||
NON-INTEREST EXPENSE
|
||||||||
Salaries and employee benefits
|
|
|
||||||
Occupancy and equipment
|
|
|
||||||
Data processing
|
|
|
||||||
Advertising and promotion
|
|
|
||||||
Acquisition costs
|
|
|
||||||
Professional fees
|
|
|
||||||
Other expenses
|
|
|
||||||
Total non-interest expense
|
|
|
||||||
Income before income tax expense
|
|
|
||||||
Income tax expense
|
|
|
||||||
NET INCOME
|
$
|
|
$
|
|
||||
EARNINGS PER COMMON SHARE - BASIC
|
$
|
|
$
|
|
||||
EARNINGS PER COMMON SHARE - DILUTED
|
$
|
|
$
|
|
Three Months Ended
December 31,
|
||||||||
2021
|
2020
|
|||||||
Net income
|
$
|
|
$
|
|
||||
Other comprehensive income, net of tax:
|
||||||||
Change in unrealized gain on securities available for sale arising during the period, net of tax of $
|
|
|
||||||
Total other comprehensive income, net of tax
|
|
|
||||||
Total comprehensive income, net of tax
|
$
|
|
$
|
|
Three Months Ended December 31, 2021
|
||||||||||||||||||||||||
Common
Stock
(Shares)
|
Common
Stock
|
Surplus
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Total
Stockholders’
Equity
|
|||||||||||||||||||
Beginning balance as of October 1, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive income, net of tax
|
-
|
|
|
|
|
|
||||||||||||||||||
Stock-based compensation
|
(
|
)
|
|
|
|
|
|
|||||||||||||||||
Issuance of common stock in lieu of directors’ fees
|
|
|
|
|
|
|
||||||||||||||||||
Ending balance as of December 31, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended December 31, 2020
|
||||||||||||||||||||||||
Common
Stock
(Shares)
|
Common
Stock
|
Surplus
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Total
Stockholders’
Equity
|
|||||||||||||||||||
Beginning balance as of October 1, 2020
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive income, net of tax
|
-
|
|
|
|
|
|
||||||||||||||||||
Stock-based compensation
|
|
|
|
|
|
|
||||||||||||||||||
Issuance of common stock
|
|
|
|
|
|
|
||||||||||||||||||
Ending balance as of December 31, 2020
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
Provision for loan losses
|
|
|
||||||
Depreciation and amortization
|
|
|
||||||
Originations of loans held for sale
|
( |
) | ||||||
Proceeds from sales of loans held for sale
|
|
|
||||||
Net gain on sale of loans
|
(
|
)
|
(
|
)
|
||||
Stock-based compensation
|
|
|
||||||
Net accretion of premiums, discounts and loan fees and costs
|
(
|
)
|
(
|
)
|
||||
Amortization of intangible assets
|
||||||||
Amortization of debt issuance costs
|
|
|
||||||
Loan servicing rights valuation adjustments
|
|
|
||||||
Deferred tax expense
|
|
|
||||||
Decrease in accrued interest receivable
|
|
|
||||||
Decrease (increase) in other assets
|
(
|
)
|
|
|||||
Increase (decrease) in accrued interest payable
|
(
|
)
|
|
|||||
Increase in other liabilities
|
|
|
||||||
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
Cash flows from investing activities:
|
||||||||
Purchases of securities available for sale
|
|
(
|
)
|
|||||
Purchases of restricted securities
|
(
|
)
|
|
|||||
Principal repayments of securities held to maturity
|
|
|
||||||
Principal repayments of securities available for sale
|
|
|
||||||
Redemptions of restricted securities
|
|
|
||||||
Proceeds from sales of loans
|
|
|
||||||
Net increase in loans
|
(
|
)
|
(
|
)
|
||||
Purchases of premises and equipment
|
(
|
)
|
(
|
)
|
||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Net increase in deposits
|
|
|
||||||
Advances of term FHLB borrowings
|
||||||||
Repayments of Federal Home Loan Bank advances
|
(
|
)
|
(
|
)
|
||||
Repayments of Federal Reserve Bank borrowings
|
(
|
)
|
(
|
)
|
||||
Proceeds from issuance of subordinated debentures, net of issuance costs
|
|
|
||||||
Repayment of note payable
|
|
(
|
)
|
|||||
Net proceeds from issuance of common stock
|
|
|
||||||
Net cash provided by (used in) financing activities
|
(
|
)
|
|
|||||
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|||||
Cash and cash equivalents, beginning of period
|
|
|
||||||
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
||||
Supplemental cash flow information:
|
||||||||
Interest paid
|
$
|
|
$
|
|
||||
Income taxes paid
|
|
|
|
|
||||
Supplemental non-cash disclosure:
|
||||||||
Transfers from portfolio loans to loans held-for-sale
|
$
|
|
$
|
|
(in thousands)
|
As Recorded
by Savoy
|
Fair Value
Adjustments
|
|
As Recorded
by Hanover
|
|||||||||
Assets
|
|
||||||||||||
Cash and due from banks
|
$
|
|
$
|
|
|
$
|
|
||||||
Investment securities available-for-sale
|
|
|
|
|
|||||||||
Loans held for sale
|
|
|
|
|
|||||||||
Loans held for investment
|
|
|
(a)
|
|
|||||||||
Premises and equipment, net
|
|
(
|
)
|
(b)
|
|
||||||||
Core deposit intangible
|
|
|
(c)
|
|
|||||||||
Accrued interest receivable
|
|
(
|
)
|
(d)
|
|
||||||||
Other assets
|
|
(
|
)
|
(e)
|
|
||||||||
Total assets acquired
|
$
|
|
$
|
|
|
|
|||||||
|
|
||||||||||||
Liabilities
|
|
||||||||||||
Deposits
|
$
|
|
$
|
|
(f)
|
|
|||||||
Borrowings
|
|
|
(g)
|
|
|||||||||
Accrued interest payable
|
|
|
|
|
|||||||||
Other liabilities and accrued expenses
|
|
(
|
)
|
(h)
|
|
||||||||
Total liabilities assumed
|
$
|
|
$
|
|
|
|
|||||||
|
|
||||||||||||
Net assets acquired
|
|
|
|||||||||||
Total consideration
|
|
|
|||||||||||
Goodwill
|
|
$
|
|
(a) |
|
(b) |
|
(c) |
|
(d) |
|
(e) |
|
(f) |
|
(g) |
|
(h) |
|
(in thousands, except share data)
|
||||
Common stock issued (
|
$
|
|
||
Cash payments to common shareholders
|
|
|||
Total consideration paid
|
$
|
|
(in thousands)
|
|
|||
Contractually required principal and interest at acquisition
|
$
|
|
||
Contractual cash flows not expected to be collected (non-accretable discount)
|
( |
) | ||
Expected cash flows at acquisition
|
|
|||
Interest component of expected cash flows (accretable discount)
|
(
|
)
|
||
Fair value of acquired purchased credit impaired loans
|
$
|
|
Three Months Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(in
thousands, except share and per share data) |
||||||||
Basic earnings per common share
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Weighted average common shares outstanding
|
|
|
||||||
Basic earnings per common share
|
$
|
|
$
|
|
||||
Diluted earnings per common share
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Weighted average common shares outstanding for basic
earnings per common share
|
|
|
||||||
Add: dilutive effects of assumed exercises of stock
options
|
|
|
||||||
Average shares and dilutive potential common shares
|
|
|
||||||
Diluted earnings per common share
|
$
|
|
$
|
|
December 31, 2021
|
||||||||||||||||
(in thousands)
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Fair
Value
|
||||||||||||
Available for sale:
|
||||||||||||||||
U.S. GSE residential mortgage-backed securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Corporate bonds
|
|
|
|
|
||||||||||||
Total available for sale securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Held to maturity:
|
||||||||||||||||
U.S. GSE residential mortgage-backed securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
U.S. GSE commercial mortgage-backed securities
|
|
|
|
|
||||||||||||
Total held to maturity securities
|
|
|
|
|
||||||||||||
Total investment securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
September 30, 2021
|
||||||||||||||||
(in thousands)
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Fair
Value
|
||||||||||||
Available for sale:
|
||||||||||||||||
U.S. GSE residential mortgage-backed securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Corporate bonds
|
|
|
|
|
||||||||||||
Total available for sale securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Held to maturity:
|
||||||||||||||||
U.S. GSE residential mortgage-backed securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
U.S. GSE commercial mortgage-backed securities
|
|
|
|
|
||||||||||||
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
Total held to maturity securities
|
|
|
(
|
)
|
|
|||||||||||
Total investment securities
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
December 31, 2021
|
||||||||
(in thousands) |
Amortized
Cost
|
Fair
Value
|
||||||
Securities
available for sale:
|
||||||||
Five to ten years
|
$
|
|
$
|
|
||||
U.S. GSE residential
mortgage-backed securities
|
|
|
||||||
Total
securities available for sale
|
|
|
||||||
Securities held
to maturity:
|
||||||||
One to five years
|
|
|
||||||
Five to ten years
|
|
|
||||||
U.S. GSE residential
mortgage-backed securities
|
|
|
||||||
U.S. GSE commercial
mortgage-backed securities
|
|
|
||||||
Total
securities held to maturity
|
|
|
||||||
Total
investment securities
|
$
|
|
$
|
|
December 31, 2021
|
September 30, 2021
|
|||||||
(in
thousands)
|
||||||||
Residential real estate
|
$
|
|
$
|
|
||||
Multi-family
|
|
|
||||||
Commercial real estate
|
|
|
||||||
Commercial and industrial
|
|
|
||||||
Construction and land
development
|
|
|
||||||
Consumer
|
|
|
||||||
Gross loans
|
|
|
||||||
Net deferred costs (fees)
|
|
|
||||||
Total loans
|
|
|
||||||
Allowance for loan losses
|
(
|
)
|
(
|
)
|
||||
Total
loans, net
|
$
|
|
$
|
|
December 31,
2021
|
||||
(in thousands)
|
||||
Commercial real estate
|
$
|
|
||
Commercial and industrial
|
|
|||
Total recorded investment
|
$
|
|
(in thousands)
|
Three Months
Ended
December 31,
2021
|
|||
Balance at beginning of period
|
$
|
|
||
Accretable differences
acquired
|
|
|||
Accretion
|
(
|
)
|
||
Adjustments to accretable
difference due to changes in expected cash flows
|
|
|||
Other changes, net
|
|
|||
Ending balance
|
$
|
|
Three Months Ended December
31, 2021
|
||||||||||||||||||||||||||||
Residential
Real Estate
Loans
|
Multi-
Family
Loans
|
Commercial
Real Estate
Loans
|
Commercial
and
Industrial
Loans |
Construction
and Land
Development
Loans
|
Consumer
Loans
|
Total
|
||||||||||||||||||||||
(in thousands)
|
||||||||||||||||||||||||||||
Allowance
for loan losses:
|
||||||||||||||||||||||||||||
Beginning
Balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Charge-offs
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||||||||||||||||
Recoveries
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Provision
(credit) for
|
||||||||||||||||||||||||||||
loan
losses
|
(
|
)
|
|
|
|
|
|
|
||||||||||||||||||||
Ending
Balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended December 31, 2020
|
||||||||||||||||||||||||||||
Residential
Real Estate
Loans |
Multi-
Family
Loans
|
Commercial
Real Estate
Loans
|
Commercial
and
Industrial
Loans
|
Construction
and Land
Development
Loans
|
Consumer
Loans
|
Total
|
||||||||||||||||||||||
(in
thousands)
|
||||||||||||||||||||||||||||
Allowance
for loan losses:
|
||||||||||||||||||||||||||||
Beginning
Balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Charge-offs
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Recoveries
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Provision
(credit) for
|
||||||||||||||||||||||||||||
loan
losses
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|||||||||||||||||||
Ending
Balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
December 31, 2021
|
||||||||||||||||||||||||||||
(in
thousands)
|
Residential
Real Estate
|
Multi-
Family
|
Commercial
Real Estate
|
Commercial
and
Industrial
|
Construction
and Land
Development
|
Consumer
|
Total
|
|||||||||||||||||||||
Allowance for loan losses:
|
||||||||||||||||||||||||||||
Individually
evaluated for impairment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Collectively
evaluated for impairment
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchased-credit
impaired
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
allowance for loan losses
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Loans:
|
||||||||||||||||||||||||||||
Individually
evaluated for impairment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Collectively
evaluated for impairment
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchased-credit
impaired
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
loans held for investment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
September 30, 2021
|
||||||||||||||||||||||||||||
(in
thousands)
|
Residential
Real Estate
|
Multi-
Family
|
Commercial
Real Estate
|
Commercial
and
Industrial
|
Construction
and Land
Development
|
Consumer
|
Total
|
|||||||||||||||||||||
Allowance for loan losses:
|
||||||||||||||||||||||||||||
Individually
evaluated for impairment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Collectively
evaluated for impairment
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchased-credit
impaired
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
allowance for loan losses
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Loans:
|
||||||||||||||||||||||||||||
Individually
evaluated for impairment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||
Collectively
evaluated for impairment
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Purchased-credit
impaired
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total
loans held for investment
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
December 31, 2021
|
September 30, 2021
|
|||||||||||||||||||||||
(in thousands)
|
Unpaid
Principal
Balance
|
Recorded
Investment
|
Allowance
Allocated
|
Unpaid
Principal
Balance
|
Recorded
Investment
|
Allowance
Allocated
|
||||||||||||||||||
With no
related allowance recorded:
|
||||||||||||||||||||||||
Residential real estate
|
$
|
|
$
|
|
$
|
-
|
$
|
|
$
|
|
$
|
-
|
||||||||||||
Multi-family
|
|
|
-
|
|
|
-
|
||||||||||||||||||
Commercial real estate
|
|
|
-
|
|
|
-
|
||||||||||||||||||
Commercial and industrial
|
|
|
-
|
|
|
-
|
||||||||||||||||||
Total
|
$
|
|
$
|
|
$
|
-
|
$
|
|
$
|
|
$
|
-
|
Three Months Ended December 31,
|
||||||||||||||||
2021
|
2020
|
|||||||||||||||
(in thousands)
|
Average
Recorded
Investment
|
Interest
Income
Recognized (1)
|
Average
Recorded
Investment
|
Interest
Income
Recognized (1)
|
||||||||||||
Residential real estate
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Multi-family
|
|
|
|
|
||||||||||||
Commercial real estate
|
|
|
|
|
||||||||||||
Commercial and industrial
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
(in thousands)
|
Past Due and Non-Accrual
|
||||||||||||||||||||||||||||||||||
December
31, 2021
|
30 - 59 days
past due and
accruing
|
60 - 89 days
past due and
accruing
|
Greater than
89 days past
due and
accruing
|
Non-accrual
|
Total past
due and non-
accrual
|
Purchased
credit
impaired
|
Current
|
Total
|
|||||||||||||||||||||||||||
Residential real estate
|
$
|
|
$
|
|
$
|
|
$
|
|
(1
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||||||
Multi-family
|
|
|
|
|
(2
|
)
|
|
|
|
|
|||||||||||||||||||||||||
Commercial real estate
|
|
|
|
|
(3
|
)
|
|
|
|
|
|||||||||||||||||||||||||
Commercial and industrial
|
|
|
|
|
(4
|
)
|
|
|
|
|
|||||||||||||||||||||||||
Construction and land
development
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Consumer
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
(in thousands)
|
Past Due and Non-Accrual
|
||||||||||||||||||||||||||||||||||
September 30, 2021
|
30 - 59 days
past due and
accruing
|
60 - 89 days
past due and
accruing
|
Greater than
89 days past
due and
accruing
|
Non-accrual
|
Total past
due and non-
accrual
|
Purchased
credit
impaired
|
Current
|
Total
|
|||||||||||||||||||||||||||
Residential real estate
|
$
|
|
$
|
|
$
|
|
$
|
|
(1
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||||||
Multi-family
|
|
|
|
|
(2
|
)
|
|
|
|
|
|||||||||||||||||||||||||
Commercial real estate
|
|
|
|
|
(3
|
)
|
|
|
|
|
|||||||||||||||||||||||||
Commercial and industrial
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Construction and land
development
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Consumer
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
December 31, 2021
|
||||||||||||||||||||
(in thousands)
|
Pass
|
Special
Mention
|
Substandard
|
Doubtful
|
Total
|
|||||||||||||||
Real Estate:
|
||||||||||||||||||||
Residential
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Multi-family
|
|
|
|
|
|
|||||||||||||||
Commercial
|
|
|
|
|
|
|||||||||||||||
Commercial and industrial
|
|
|
|
|
|
|||||||||||||||
Construction and land
development
|
|
|
|
|
|
|||||||||||||||
Consumer
|
|
|
|
|
|
|||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
September 30, 2021
|
||||||||||||||||||||
(in thousands)
|
Pass
|
Special
Mention
|
Substandard
|
Doubtful
|
Total
|
|||||||||||||||
Real Estate:
|
||||||||||||||||||||
Residential
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Multi-family
|
|
|
|
|
|
|||||||||||||||
Commercial
|
|
|
|
|
|
|||||||||||||||
Commercial and industrial
|
|
|
|
|
|
|||||||||||||||
Construction and land
development
|
|
|
|
|
|
|||||||||||||||
Consumer
|
|
|
|
|
|
|||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Aggregate
Intrinsic
Value
|
Weighted-
Average
Remaining
Contractual
Term
|
||||||||||
Outstanding, October 1, 2021
|
|
$
|
|
$
|
|
|
|||||||
Granted |
|||||||||||||
Exercised
|
|
|
|||||||||||
Forfeited
|
|
|
|||||||||||
Outstanding, December 31, 2021
(1)
|
|
$
|
|
$
|
|
|
Number of Shares
|
Weighted-
Average
Grant Date
Fair Value
|
|||||||
Unvested, October 1, 2021
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Vested
|
(
|
)
|
|
|||||
Forfeited
|
(
|
)
|
|
|||||
Unvested, December 31, 2021
|
|
$
|
|
Actual Capital
|
Minimum Capital
Adequacy
Requirement
|
Minimum Capital
Adequacy
Requirement
with Capital
Conservation Buffer
|
Minimum to Be
Well Capitalized
Under
Prompt Corrective
Action Provisions
|
|||||||||||||||||||||||||||||
Amount
|
Ratio
|
Amount
|
Ratio
|
Amount
|
Ratio
|
Amount
|
Ratio
|
|||||||||||||||||||||||||
December 31, 2021
|
||||||||||||||||||||||||||||||||
Total capital to risk-weighted
assets
|
$
|
|
|
%
|
$
|
|
|
%
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||||||||||
Tier 1 capital to risk-weighted
assets
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
||||||||||||||||||||
Common equity tier 1 capital to
risk-weighted assets
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
||||||||||||||||||||
Tier 1 capital to adjusted average
assets (leverage)
|
|
|
%
|
|
|
%
|
N/A
|
N/A
|
|
|
%
|
|||||||||||||||||||||
September
30, 2021
|
||||||||||||||||||||||||||||||||
Total capital to risk-weighted
assets
|
$
|
|
|
%
|
$
|
|
|
%
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||||||||||
Tier 1 capital to risk-weighted
assets
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
||||||||||||||||||||
Common equity tier 1 capital to
risk-weighted assets
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
||||||||||||||||||||
Tier 1 capital to adjusted average
assets (leverage)
|
|
|
%
|
|
|
%
|
N/A
|
N/A
|
|
|
%
|
• |
Level 1: Valuation is based upon unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement
date.
|
• |
Level 2: Fair value is calculated using significant inputs other than quoted market prices that are directly or indirectly observable for the asset or liability. The valuation may rely
on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the
asset or liability (such as interest rates, rate volatility, prepayment speeds, credit ratings,) or inputs that are derived principally or corroborated by market data, by correlation, or other means.
|
• |
Level 3: Inputs for determining the fair value of the respective assets or liabilities are not observable. Level 3 valuations are reliant upon pricing models and techniques that
require significant management judgment or estimation.
|
December 31, 2021 | ||||||||||||||||
Fair Value
Measurements Using
|
||||||||||||||||
(In thousands)
|
Carrying
Amount
|
Quoted Prices
In Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
Financial assets: |
||||||||||||||||
Available-for-sale securities:
|
||||||||||||||||
U.S. GSE residential
mortgage-backed securities
|
$
|
|
$ |
$
|
|
$
|
|
|||||||||
Corporate bonds
|
|
|
|
|||||||||||||
Mortgage servicing rights
|
|
|
|
|||||||||||||
Total
|
$
|
|
$ |
$
|
|
$
|
|
September 30, 2021
|
||||||||||||||||
Fair Value
Measurements Using
|
||||||||||||||||
(In thousands)
|
Carrying
Amount
|
Quoted Prices
In Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||||||
Financial assets: | ||||||||||||||||
Available-for-sale securities:
|
||||||||||||||||
U.S. GSE residential
mortgage-backed securities
|
$
|
|
$ |
$
|
|
$
|
|
|||||||||
Corporate bonds
|
|
|
|
|||||||||||||
Mortgage servicing rights
|
|
|
|
|||||||||||||
Total
|
$
|
|
$ |
$
|
|
$
|
|
Three Months Ended December 31,
|
||||||||
(in thousands) |
2021
|
2020 |
||||||
Balance,
October 1
|
$
|
|
$
|
|
||||
Additions | ||||||||
Adjustment to fair value
|
(
|
)
|
(
|
)
|
||||
Balance,
December 31
|
$
|
|
$
|
|
December 31, 2021 | ||||||||||||||||||||
Fair Value Measurements Using:
|
||||||||||||||||||||
(In thousands)
|
Carrying
Amount
|
Quoted Prices
In Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
Fair
Value
|
|||||||||||||||
Financial
assets:
|
||||||||||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Securities held-to-maturity
|
|
|
|
|
|
|||||||||||||||
Securities available-for-sale
|
||||||||||||||||||||
Loans, net
|
|
|
|
|
||||||||||||||||
Federal Home Loan Bank stock
|
N/A | N/A | N/A | N/A | ||||||||||||||||
Accrued interest receivable
|
|
|
|
|
|
|||||||||||||||
Financial
Liabilities:
|
||||||||||||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Demand and other deposits
|
|
|
|
|
|
|||||||||||||||
Borrowings
|
|
|
|
|
|
|||||||||||||||
Subordinated debentures
|
|
|
|
|
|
|||||||||||||||
Accrued interest payable
|
|
|
|
|
|
September 30, 2021 | ||||||||||||||||||||
Fair Value Measurements Using:
|
||||||||||||||||||||
(In thousands)
|
Carrying
Amount
|
Quoted Prices
In Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
Fair
Value
|
|||||||||||||||
Financial
assets:
|
||||||||||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Securities held-to-maturity
|
|
|
|
|
||||||||||||||||
Securities available-for-sale
|
||||||||||||||||||||
Loans, net
|
|
|
|
|
|
|||||||||||||||
Federal Home Loan Bank stock
|
N/A | N/A | N/A | N/A | ||||||||||||||||
Accrued interest receivable
|
|
|
|
|
|
|||||||||||||||
Financial
Liabilities:
|
||||||||||||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Demand and other deposits
|
|
|
|
|
|
|||||||||||||||
Borrowings
|
|
|
|
|
|
|||||||||||||||
Subordinated debentures
|
|
|
|
|
|
|||||||||||||||
Accrued interest payable
|
|
|
|
|
|
|
Balance at December 31, 2021
|
|||||||
Contractual Maturity
|
Amount
|
Weighted Average Rate
|
||||||
2022
|
$
|
|
|
%
|
||||
2023
|
|
|
%
|
|||||
2024
|
|
|
%
|
|||||
2025
|
|
|
%
|
|||||
Total
|
$
|
|
|
%
|
|
Balance at September 30, 2021
|
|||||||
Contractual Maturity
|
Amount
|
Weighted Average Rate
|
||||||
2022
|
$
|
|
|
%
|
||||
2023
|
|
|
%
|
|||||
2024
|
|
|
%
|
|||||
2025
|
|
|
%
|
|||||
Total
|
$
|
|
|
%
|
(in thousands)
|
Unrealized Gains and
Losses on Available-
for-Sale Debt
Securities
|
Total
|
||||||
Balance at October 1, 2021
|
$
|
|
$
|
|
||||
Other comprehensive income
|
|
|
||||||
Balance at December 31, 2021
|
$
|
|
$
|
|
||||
Balance at October 1, 2020
|
$
|
|
$
|
|
||||
Other comprehensive income
|
|
|
||||||
Balance at December 31, 2020
|
$
|
|
$
|
|
• |
The anticipated cost savings and other synergies of the merger may take longer to be realized or may not be achieved in their entirety, and attrition in key client, partner and other relationships relating to the merger may be greater
than expected;
|
• |
The ability to achieve anticipated merger-related operational efficiencies;
|
• |
The ability to enhance revenue through increased market penetration, expanded lending capacity and product offerings;
|
• |
Changes in monetary and fiscal policies of the FRB and the U. S. Government, particularly related to changes in interest rates;
|
• |
Changes in general economic conditions;
|
• |
Occurrence of natural or man-made disasters or calamities, including health emergencies, the spread of infectious diseases, pandemics such as COVID-19, or outbreaks of hostilities, or the effects of climate change, and the ability of
the Company to deal effectively with disruptions caused by the foregoing;
|
• |
The effects of COVID-19, including, but not limited to, the length of time that the pandemic continues, the effectiveness of the vaccination program and accompanying vaccination rates, the development of new variants of the virus and
their impact, the potential future imposition of further restrictions on travel, the measures adopted by federal, state and local governments, the health of employees and the potential inability of employees to work due to illness,
quarantine or government mandates, the business continuity plans of customers and vendors, the increased likelihood of cybersecurity risk, data breaches, or fraud due to employees working from home, the ability of borrowers to repay their
loans and the effect of the pandemic on the general economy and businesses of borrowers;
|
• |
Legislative or regulatory changes;
|
• |
Downturns in demand for loan, deposit and other financial services in the Company’s market area;
|
• |
Increased competition from other banks and non-bank providers of financial services;
|
• |
Technological changes and increased technology-related costs; and
|
• |
Changes in accounting principles, or the application of generally accepted accounting principles.
|
Three months ended
December 31,
|
Over/
(under) |
||||||||||||
|
2021
|
2020
|
2020
|
||||||||||
Revenue (1)
|
$
|
17,644
|
$
|
7,613
|
131.8
|
%
|
|||||||
Non-interest expense
|
8,264
|
5,590
|
47.8
|
%
|
|||||||||
Provision for loan losses
|
900
|
100
|
800.0
|
%
|
|||||||||
Net income
|
6,537
|
1,519
|
330.3
|
%
|
|||||||||
Net income per common share - diluted
|
1.16
|
0.36
|
224.3
|
%
|
|||||||||
Return on average assets
|
1.80
|
%
|
0.71
|
%
|
109
|
|
bp | ||||||
Return on average common stockholders' equity
|
20.52
|
%
|
7.62
|
%
|
1,290
|
bp | |||||||
Tier 1 leverage ratio
|
9.92
|
%
|
12.04
|
%
|
(212
|
)
|
bp | ||||||
Common equity tier 1 risk-based capital ratio
|
14.44
|
%
|
21.49
|
%
|
(705
|
)
|
bp | ||||||
Tier 1 risk-based capital ratio
|
14.44
|
%
|
21.49
|
%
|
(705
|
)
|
bp | ||||||
Total risk-based capital ratio
|
15.52
|
%
|
22.75
|
%
|
(723
|
)
|
bp | ||||||
Tangible common equity ratio (non-GAAP)
|
7.63
|
%
|
8.93
|
%
|
(130
|
)
|
bp | ||||||
Total common stockholders' equity/total assets (2)
|
8.87
|
%
|
9.13
|
%
|
(25
|
)
|
bp |
bp - denotes basis points; 100 bp equals 1%.
(1) Represents net interest income plus total non-interest income.
(2) The ratio of total common stockholders' equity to total assets is the most comparable GAAP measure to the non-GAAP tangible common equity ratio
presented herein.
|
Ratios
|
||||||||||||||||
Total common stockholders' equity
|
$
|
129,379
|
Total assets
|
$
|
1,458,180
|
8.87
|
%
|
(1)
|
||||||||
Less: goodwill
|
(19,168
|
)
|
Less: goodwill
|
(19,168
|
)
|
|||||||||||
Less: core deposit intangible
|
(459
|
)
|
Less: core deposit intangible
|
(459
|
)
|
|||||||||||
Tangible common equity
|
$
|
109,752
|
Tangible assets
|
$
|
1,438,553
|
7.63
|
%
|
(2)
|
(1) The ratio of total common stockholders' equity to total assets is the most comparable GAAP measure to the non-GAAP tangible common equity ratio
presented herein.
(2) TCE ratio
|
2021
|
2020
|
||||||||||||||||||||||||
Average
Balance
|
Interest
|
Average
Yield/Cost
|
Average
Balance
|
Interest
|
Average
Yield/Cost
|
||||||||||||||||||||
Assets:
|
|||||||||||||||||||||||||
Interest-earning assets:
|
|||||||||||||||||||||||||
Loans
|
$
|
1,253,827
|
$
|
16,381
|
5.18
|
%
|
$
|
724,751
|
$
|
9,258
|
5.07
|
%
|
|||||||||||||
Investment securities
|
15,634
|
155
|
3.93
|
%
|
16,520
|
173
|
4.15
|
%
|
|||||||||||||||||
Interest-earning cash
|
106,660
|
38
|
0.14
|
%
|
78,958
|
21
|
0.11
|
%
|
|||||||||||||||||
FHLB stock and other investments
|
5,252
|
42
|
3.17
|
%
|
3,922
|
45
|
4.55
|
%
|
|||||||||||||||||
Total interest-earning assets
|
1,381,373
|
16,616
|
4.77
|
%
|
824,151
|
9,497
|
4.57
|
%
|
|||||||||||||||||
Non interest-earning assets:
|
|||||||||||||||||||||||||
Cash and due from banks
|
8,264
|
4,709
|
|||||||||||||||||||||||
Other assets
|
49,011
|
24,300
|
|||||||||||||||||||||||
Total assets
|
$
|
1,438,648
|
$
|
853,160
|
|||||||||||||||||||||
Liabilities and stockholders' equity:
|
|||||||||||||||||||||||||
Interest-bearing liabilities:
|
|||||||||||||||||||||||||
Savings, NOW and money market deposits
|
$
|
609,251
|
$
|
366
|
0.24
|
%
|
$
|
186,894
|
$
|
117
|
0.25
|
%
|
|||||||||||||
Time deposits
|
346,448
|
491
|
0.56
|
%
|
391,442
|
1,454
|
1.47
|
%
|
|||||||||||||||||
Total savings and time deposits
|
955,699
|
857
|
0.36
|
%
|
578,336
|
1,571
|
1.08
|
%
|
|||||||||||||||||
Fed funds purchased & FHLB & FRB advances
|
126,058
|
160
|
0.50
|
%
|
78,937
|
221
|
1.11
|
%
|
|||||||||||||||||
Note payable
|
-
|
-
|
0.00
|
%
|
1,303
|
73
|
22.23
|
%
|
(1) | ||||||||||||||||
Subordinated debentures
|
24,499
|
330
|
5.34
|
%
|
22,899
|
305
|
5.28
|
%
|
|||||||||||||||||
Total interest-bearing liabilities
|
1,106,256
|
1,347
|
0.48
|
%
|
681,475
|
2,170
|
1.26
|
%
|
|||||||||||||||||
Demand deposits
|
192,161
|
83,701
|
|||||||||||||||||||||||
Other liabilities
|
13,834
|
8,921
|
|||||||||||||||||||||||
Total liabilities
|
1,312,251
|
774,097
|
|||||||||||||||||||||||
Stockholders' equity
|
126,397
|
79,063
|
|||||||||||||||||||||||
Total liabilities & stockholders' equity
|
$
|
1,438,648
|
$
|
853,160
|
|||||||||||||||||||||
Net interest rate spread
|
4.29
|
%
|
3.31
|
%
|
|||||||||||||||||||||
Net interest income/margin
|
$
|
15,269
|
4.39
|
%
|
$
|
7,327
|
3.53
|
%
|
Three months ended
December 31,
|
Over/
(under) |
|||||||||||
2021
|
2020
|
2020
|
||||||||||
Loan servicing and fee income
|
$
|
690
|
$
|
83
|
731.3
|
%
|
||||||
Service charges on deposit accounts
|
63
|
15
|
320.0
|
|||||||||
Net gain on sale of loans held for sale
|
1,492
|
181
|
724.3
|
|||||||||
Other income
|
130
|
7
|
1,757.1
|
|||||||||
Total non-interest income
|
$
|
2,375
|
$
|
286
|
730.4
|
%
|
Three months ended
December 31,
|
Over/
(under) |
|||||||||||
|
2021
|
2020
|
2020
|
|||||||||
Salaries and employee benefits
|
$
|
4,939
|
$
|
3,108
|
58.9
|
%
|
||||||
Occupancy and equipment
|
1,413
|
1,171
|
20.7
|
|||||||||
Data processing
|
366
|
245
|
49.4
|
|||||||||
Advertising and promotion
|
33
|
48
|
(31.3
|
)
|
||||||||
Acquisition costs
|
-
|
145
|
(100.0
|
)
|
||||||||
Professional fees
|
499
|
412
|
21.1
|
|||||||||
Other expenses
|
1,014
|
461
|
120.0
|
|||||||||
Total non-interest expense
|
$
|
8,264
|
$
|
5,590
|
47.8
|
%
|
As of or for the three months ended
|
||||||||||||
12/31/2021
|
9/30/2021
|
12/31/2020
|
||||||||||
Non-accrual loans
|
$
|
6,115
|
$
|
7,028
|
$
|
4,053
|
||||||
Non-accrual loans held for sale
|
-
|
-
|
-
|
|||||||||
Other real estate owned
|
-
|
-
|
-
|
|||||||||
Total non-performing assets (1)
|
$
|
6,115
|
$
|
7,028
|
$
|
4,053
|
||||||
Purchased credit-impaired loans 90 days or more past due and still accruing
|
$
|
2,501
|
$
|
2,519
|
$
|
318
|
||||||
Performing TDRs
|
455
|
455
|
454
|
|||||||||
Loans held for sale
|
-
|
-
|
4,150
|
|||||||||
Loans held for investment
|
1,277,434
|
1,247,125
|
728,752
|
|||||||||
Allowance for loan losses:
|
||||||||||||
Beginning balance
|
$
|
8,552
|
$
|
7,852
|
$
|
7,869
|
||||||
Provision
|
900
|
700
|
100
|
|||||||||
Charge-offs
|
(66
|
)
|
-
|
-
|
||||||||
Recoveries
|
-
|
-
|
10
|
|||||||||
Ending balance
|
$
|
9,386
|
$
|
8,552
|
$
|
7,979
|
||||||
Allowance for loan losses as a % of total loans (2)
|
0.73
|
%
|
0.69
|
%
|
1.09
|
%
|
||||||
Allowance for loan losses as a % of non-accrual loans (2)
|
153
|
%
|
122
|
%
|
197
|
%
|
||||||
Non-accrual loans as a % of total loans (2)
|
0.48
|
%
|
0.56
|
%
|
0.56
|
%
|
||||||
Non-performing assets as a % of total loans, loans held for sale and other real estate owned
|
0.48
|
%
|
0.56
|
%
|
0.55
|
%
|
||||||
Non-performing assets as a % of total assets
|
0.42
|
%
|
0.47
|
%
|
0.46
|
%
|
||||||
Non-performing assets, purchased credit-impaired loans 90 days or more past due and still accruing and performing TDRs, to total loans held for sale and investment
|
0.71
|
%
|
0.80
|
%
|
0.66
|
%
|
At December 31, 2021
|
||||||||||||||||||||||||||||
Interest Rates
|
Estimated
|
Estimated Change in EVE
|
Interest Rates
|
Estimated
|
Estimated Change in NII (1)
|
|||||||||||||||||||||||
(basis points)
|
EVE
|
Amount
|
%
|
(basis points)
|
NII (1)
|
Amount
|
%
|
|||||||||||||||||||||
+400
|
$
|
154,270
|
$
|
(34,721
|
)
|
(18.4
|
)
|
+400
|
$
|
53,720
|
$
|
(298
|
)
|
(0.6
|
)
|
|||||||||||||
+300
|
163,684
|
(25,307
|
)
|
(13.4
|
)
|
+300
|
54,192
|
174
|
0.3
|
|||||||||||||||||||
+200
|
171,008
|
(17,983
|
)
|
(9.5
|
)
|
+200
|
54,471
|
453
|
0.8
|
|||||||||||||||||||
+100
|
177,731
|
(11,260
|
)
|
(6.0
|
)
|
+100
|
54,365
|
347
|
0.6
|
|||||||||||||||||||
0
|
188,991
|
0
|
54,018
|
|||||||||||||||||||||||||
-100
|
206,319
|
17,328
|
9.2
|
-100
|
51,577
|
(2,441
|
)
|
(4.5
|
)
|
31.1
|
Certification of principal executive officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
Certification of principal financial officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
Certification of principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
Certification of principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
HANOVER BANCORP, INC.
|
||
Dated: February 7, 2022
|
/s/ Michael P. Puorro
|
|
Michael P. Puorro
|
||
Chairman & Chief Executive Officer
|
||
(principal executive officer)
|
||
Dated: February 7, 2022
|
/s/ Lance P. Burke
|
|
Lance P. Burke
|
||
Executive Vice President & Chief Financial Officer
|
||
(principal financial and accounting officer)
|
Exhibit
Number
|
Description
|
Certification of principal executive officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Certification of principal financial officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Certification of principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
Certification of principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
1. |
I have reviewed this Quarterly Report on Form 10-Q of Hanover Bancorp, Inc.;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c. |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
|
d. |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and
report financial information; and
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1. |
I have reviewed this Quarterly Report on Form 10-Q of Hanover Bancorp, Inc.;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c. |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
|
d. |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report
financial information; and
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|